Coronavirus can exploit your antiviral defence mechanisms for replication

Press Release 03:33 PM, 3 Aug, 2022
Coronavirus can exploit your antiviral defence mechanisms for replication

Hong Kong: Researchers from The Department of Microbiology, School of Clinical Medicine, The University of Hong Kong (HKUMed) revealed insights into the mechanism of how coronaviruses including SARS-CoV-2, SARS-CoV-1, and MERS-CoV exploit a host protease called ‘cysteine-aspartic protease 6’ (caspase-6) for efficient replication

The human body has an efficient immune response to infection

Upon entering the host cells, the ribonucleic acid (RNA) of coronaviruses will trigger the infected cells to secrete interferons that can inhibit virus replication within the infected cells, and reduce the risk of infection among other uninfected cells. Meanwhile, the host cells will also undergo apoptosis process, a programmed cell death process which will eliminate cells from becoming factories of viral replication. Hence the interferon reaction and apoptosis process are the most important anti-virus mechanisms in human and animal cells.

Apoptosis is executed by cysteine-aspartic protease in human and animal cells, by which infected cells are eradicated to inhibit virus replication. The HKUMed team investigated the impact of caspase-6 on coronavirus replication in a series of cell line, human ex vivo lung tissue, human intestinal organoids, and animal models. The team found that the chemical inhibition or gene depletion of caspase-6 significantly reduced coronavirus replication, while overexpressing caspase-6 efficiently promoted coronavirus replication

Research methodology and findings

In a mouse model, chemical inhibitors of caspase-6 dramatically limited mouse-adapted MERS-CoV (MERS-CoVMA) replication and significantly improved the survival of mice from 33.3% to 80%. Moreover, MERS-CoVMA replication and MERS-CoVMA-induced lung damage were markedly reduced in the lungs of caspase-6 knockout mice. Similarly, in a hamster model, the specific chemical inhibitor against caspase-6 reduced SARS-CoV-2 replication and the associated inflammatory lung damage.   

But how does the coronavirus harness caspase-6 to its benefit? Note that the interferon response is the most important and immediate antiviral defence of host cells. Our further investigations revealed that caspase-6 cleaved the coronavirus nucleocapsid (N) proteins, generating N fragments that interact with the host ‘interferon regulatory factor 3 (IRF3)’ and stop it from entering the cell nucleus to initiate the interferon response. Thus, the viral N fragments serve as interferon antagonists, which facilitate virus replication.

Significance of the study

The study shows how coronaviruses have evolved to become very successful pathogens. We reveal a novel mechanism of how coronaviruses overcome the antiviral defence of interferon response by the host cells through the exploitation of a new class of host protease, caspase-6, which is originally used by the host for executing cell apoptosis as a defence against virus infection, for its own purpose of getting better viral replication. These results further suggest that drugs can be designed against caspase-6, which can become a potential target of intervention for the antiviral treatment of all known human coronavirus infections.



Follow us on Facebook

Follow us on Twitter

Sign up for Newsletter